ImmunityBio (IBRX) Proxy Filing summary

Executive summary

• Annual meeting scheduled for June 18, 2025, at 9:30 A.M. Pacific Time, with virtual attendance available.

• Shareholders are encouraged to review proxy materials and vote by June 17, 2025.

Voting matters and shareholder proposals

• Election of eight directors is on the agenda, with board recommendations provided for each nominee.

• Proposal to approve the 2025 Equity Incentive Plan.

• Proposal to ratify Deloitte & Touche LLP as the independent registered public accounting firm for fiscal year ending December 31, 2025.

• Proxies may vote on other business that arises at the meeting.

Board of directors and corporate governance

• Director nominees include Patrick Soon-Shiong, Cheryl L. Cohen, Richard Adcock, Michael D. Blaszyk, Wesley Clark, Linda Maxwell, Christobel Selecky, and Barry J. Simon.